Neuren Pharmaceuticals Ltd Free Cash Flow Generation Index
Neuren Pharmaceuticals Ltd free cash flow generation index. Neuren Pharmaceuticals Ltd (NEU) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of AU$128.30 Million represents 1% of operating cash flow (AU$128.31 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Neuren Pharmaceuticals Ltd (2018–2023)
Free cash flow generation index of Neuren Pharmaceuticals Ltd from 2018 to 2023. Historical FCF Generation Index trend for Neuren Pharmaceuticals Ltd across 3 annual periods. See NEU free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Neuren Pharmaceuticals Ltd Free Cash Flow Generation Index by Year (2018–2023)
Neuren Pharmaceuticals Ltd free cash flow generation index by year from 2018 to 2023. Year-by-year Free Cash Flow Generation Index for Neuren Pharmaceuticals Ltd. For the full cash flow conversion analysis, see NEU cash flow metrics.
| Year | FCG Index | Free Cash Flow (AUD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.00x | AU$184.88 Million | AU$184.93 Million | AU$40.00K | ▲ +0.5% |
| 2022 | 0.99x | AU$3.58 Million | AU$3.60 Million | AU$19.00K | ▼ -0.5% |
| 2018 | 1.00x | AU$6.41 Million | AU$6.41 Million | AU$12.00K | — |